Opus Genetics, Inc. Financial Flexibility Index
Opus Genetics, Inc. financial flexibility index. Opus Genetics, Inc. (IRD) has a Financial Flexibility Index of -0.11x as of June 2026. Free cash flow of $-11.95 Million (operating CF $-11.95 Million minus capex $0.00) represents 0% of total liabilities ($105.95 Million). See IRD FCF generation index to measure how efficiently the company converts operating cash flow to free cash.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Financial Flexibility Index of Opus Genetics, Inc. (2019–2025)
Financial flexibility index of Opus Genetics, Inc. from 2019 to 2025. Historical Financial Flexibility Index trend for Opus Genetics, Inc. across 7 annual periods. Check IRD cash flow quality index to evaluate the quality of earnings relative to operating cash generation.
Opus Genetics, Inc. Financial Flexibility Index by Year (2019–2025)
Opus Genetics, Inc. financial flexibility index by year from 2019 to 2025. Year-by-year free cash flow to debt coverage for Opus Genetics, Inc.. For the full cash flow conversion analysis, see IRD cash flow metrics.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -1.01x | $-35.25 Million | $-35.25 Million | $34.90 Million | ▼ -19.0% |
| 2024 | -0.85x | $-25.58 Million | $-25.58 Million | $30.14 Million | ▼ -208.5% |
| 2023 | -0.28x | $-1.11 Million | $-1.11 Million | $4.04 Million | ▼ -105.3% |
| 2022 | 5.20x | $14.31 Million | $14.31 Million | $2.75 Million | ▲ +203.5% |
| 2021 | -5.02x | $-19.37 Million | $-19.37 Million | $3.85 Million | ▼ -2202.7% |
| 2020 | -0.22x | $-6.80 Million | $-6.80 Million | $31.15 Million | ▲ +42.9% |
| 2019 | -0.38x | $-3.57 Million | $-3.59 Million | $9.34 Million | — |